Nippon Paint Reportedly Offers Up to €7.5 Billion for Akzo Nobel Decorative Paints Business 
Rio Tinto Reports Strong Q2 Iron Ore Sales, Maintains 2026 Production Outlook 
Richemont Q1 Sales Beat Forecast as Cartier Demand Drives Strong Growth 
DeepSeek Eyes China IPO as AI Startup Seeks $71 Billion Valuation in New Funding Round 
SK Hynix Shares Drop After Strong Nasdaq Debut Despite $26 Billion ADR Listing 
DBS Targets S$1 Trillion Wealth AUM by 2030 Amid Asia Wealth Boom 
Apple Intelligence Cleared for China as Alibaba and Baidu AI Power iPhone Features 
Samsung to Launch First Yongin Chip Plant by 2029 as South Korea Speeds Up Semiconductor Hub 
Muji Owner Ryohin Keikaku Stock Soars After Raising Full-Year Earnings Forecast 
Genesis Minerals to Acquire Vault in A$5.6 Billion Deal After Regis Withdraws 
UBS Starts CarTrade Tech With Buy Rating, Sees Strong Earnings Growth and ₹4,000 Target 
SEB Q2 Profit Rises on Strong Lending, Record Fee Income, Announces New Share Buyback 
SoftBank Corp Partners With Sierra to Expand AI Customer Support Across Japan 
Arm Stock Falls After HSBC Downgrade, Citing Limited Near-Term AI Upside 
TSMC Q2 Revenue Surges 36% as AI Chip Demand Powers Growth Ahead of Earnings 
Nvidia Tightens AI Chip Sales in Asia With Stricter Customer Approval Process 
Taiwan Mangoes Head to Europe as Premium Fruit Exports Expand 
PLEASANTON, Calif., Jan. 13, 2016 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ:BABY) today announced that the Company will release its 2015 fourth quarter financial results before the market opens on Wednesday, January 27th. Natus management will host an investment-community conference call the same day beginning at 8:00 a.m. Pacific Time (11:00 a.m. Eastern Time) to discuss those results and to answer questions.
Individuals interested in listening to the conference call may do so by dialing 1-888-765-3164 for domestic callers, or 1-503-406-4075 for international callers, and entering reservation code 23993319. A telephone replay will be available for 48 hours following the conclusion of the call by dialing 1-855-859-2056 for domestic callers, or 1-404-537-3406 for international callers, and entering reservation code 23993319.
The conference call also will be available real-time via the Internet at http://investor.natus.com and a recording of the call will be available on the Company's Web site for 90 days following the completion of the call.
About Natus Medical Incorporated
Natus is a leading provider of healthcare products used for the screening, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, and balance and mobility disorders.
Additional information about Natus Medical can be found at www.natus.com.
COMPANY CONTACT: Natus Medical Incorporated Jonathan A. Kennedy Sr. Vice President and Chief Financial Officer (925) 223-6700 [email protected]
